InsidersTradesSigma
Total declarations
Companies
▲ Purchases (1 ops.)
▼ Sales (0 ops.)
Explore the complete record of transactions filed by snyderman nancy lynn MD, Director. Officer active across 3 companies, notably Alkermes plc.. In total, 10 disclosures have been logged. Total volume traded: €9k. The latest transaction was disclosed on 4 March 2022 — Acquisition. Regulator: SEC (Form 4). All data is openly available.
Declarations10 total
7,585 shares
Ordinary Shares
SEC:0001127602-22-017639:0·
€9,040427 shares@ €21.17130.0002% mcap100.0% of flow
Ordinary Shares
SEC:0001127602-22-008576:0·
Ideal exit: 29 Nov 2022 (T+270)
5,578 shares
Ordinary Shares
SEC:0001127602-21-030303·
5,578 shares
Ordinary Shares
SEC:0001127602-21-030303:0·
02,261 shares0
Common Stock
SEC:0001562180-21-006778·
02,261 shares0
Common Stock
SEC:0001562180-21-006778:0·
01,688 shares0
Common stock, par value $0.0001 per share
SEC:0001104659-21-129991·
01,688 shares0
Common stock, par value $0.0001 per share
SEC:0001104659-21-129991:0·
06,104 shares0
Ordinary Shares
SEC:0001127602-21-017790·
06,104 shares0
Ordinary Shares
SEC:0001127602-21-017790:0·
10 of 10 declarations
About snyderman nancy lynn MD
Nancy Lynn Snyderman, MD, is a Board Member at Alkermes plc, Future Health ESG Corp., and Axonics, Inc. She provides her expertise in governance and strategy, contributing to guiding decisions and ensuring compliance. Her experience in the healthcare sector is a valuable asset to the board.
